Bernice Yeung

Vice President of Analytical Development @Halozyme, Inc.

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2026 — Present

Vice President of Analytical Development @Halozyme, Inc.

View department →

Boston, MA, US

EDUCATION

N/A

University of Delaware

Bachelor’s Degree, Chemistry

N/A

Northeastern University

PhD, Analytical Chemistry

SKILLS

Pharmaceutical IndustryAssay DevelopmentHigh-Performance Liquid Chromatography (Hplc)IndCapillary ElectrophoresisFormulation DevelopmentProtein CharacterizationBiotechnologyChromatographyValidationMass SpectrometryGlpProtein Mass SpectrometryCmc AuthoringProtein ChemistryAnalytical ChemistryHplcLaboratoryDrug DevelopmentBiopharmaceuticalsFormulationProtein Formulation DevelopmentPeptidesDrug DiscoveryPurificationAnalytical Method Development and QualificationCell Culture

ABOUT BERNICE YEUNG

I am an analytical CMC professional with 25+ years of experience in biologics development. I am experienced with product characterization, method development, analytical CMC and regulatory strategies. Currently, I am the Head of Analytical Development at Halozyme Hypercon (formerly Elektrofi), responsible for all analytical activities that enable our proprietary Hypercon drug product technology, a novel approach capable of producing high concentration biologics drug products for subcutaneous delivery. Throughout my career, I have been an integral part of product and process development for numerous therapeutics spanning from pre-clinical to commercial phase. I have held roles from bench scientist to organizational leader, encompassing all disciplines in analytical science, technical and CMC strategies, in major biopharma companies including Amgen, BMS, Shire and Biogen.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.